INVEST PharmaTech: The convergence of digital health and biopharma

0
INVEST PharmaTech: The convergence of digital health and biopharma


GettyImages 1094395912

With the digital transformation of the biopharma industry in full swing, MedCity INVEST PharmaTech, a virtual conference scheduled for July 26, will bring together technology disruptors, Big Pharma and biotech leaders, investors and entrepreneurs to discuss how to adopt digital strategies to transform every aspect of the pharma industry.

To register, click here.

One panel, Pharma + Digital: Here’s how to make it a match made in heaven, will discuss strategies for better alignment and partnerships between the worlds of digital health and pharma. Panelists include:

  • Naomi Fried, PhD, CEO and Founder, Pharmstars (moderator)
  • Jessica Federer, Partner, Boston Millennia Partners
  • Joel Krikston, Managing Director Venture Investments & Head of Strategic Innovation Alliances, Merck Global Health Innovation Fund
  • Jim Parshall, Senior Director — Connected Health & Devices External Innovation, Eli Lilly and Company

Here’s a look at the rest of the agenda.

The state of AI in drug discovery (on demand)
Artificial intelligence in healthcare is finally emerging from being overhyped to showing some practical applications. If it succeeds in the realms of drug discovery, that will be a monumental achievement helping both to speed up and lower the cost for drug development. Learn from experts about where we are in leveraging AI effectively for drug discovery.

This discussion will be moderated by MedCity Biopharma Reporter Frank Vinluan.

What Covid taught us about virtual clinical trials (on demand)
When going to the hospital – very often the site of clinical trials – is no longer an option because of a pandemic, it requires the reimagining of how clinical trials are designed. But can virtual, decentralized or site-less clinical trials be as effective as traditional trials? What are the pros and cons of running such trials? Hear from experts in the field.

The future of digital medicines
Proteus Digital Health has become a cautionary tale regarding how despite huge interest and investment in digital therapeutics and ultimately regulatory approval, the product never won traction in the marketplace. What are the lessons learned? What is the landscape of digital medicines today? Learn from experts in the field of pharma, digital health and commercialization.

The panel discussions will conclude with a startup pitch contest. The theme of this mini Pitch Perfect is reinventing clinical trials.

To apply to be a speaker at INVEST PharmaTech, follow this link. The deadline to apply is May 26.

For startups interested in pitching in the Pitch Perfect contest, submit your application here.

Interested in exploring sponsorship opportunities for INVEST PharmaTech? Please email: advertising@medcitynews.com.

Screen Shot 2020 06 24 at 2.28.39 PM

Picture: Yuuji, Getty Images



Source link